期刊文献+

利拉鲁肽对2型糖尿病大鼠肾脏保护作用的研究

The Protective Effect of Liraglutide on Kidney in Type 2 Diabetic Rats
下载PDF
导出
摘要 目的观察利拉鲁肽对2型糖尿病大鼠肾脏的保护作用。方法雄性SD大鼠给予高糖高脂饲料喂养6周后空腹注射链脲佐菌素(STZ)建立2型糖尿病大鼠模型,成模的大鼠每天给予利拉鲁肽(200μg/kg体质量)皮下注射6周,与对照组相比,观察其血糖、血压、体质量、血尿素氮、血肌酐和血尿离子的变化。结果利拉鲁肽能有效降低模型大鼠的血糖、血压、体质量、血尿素氮和肌酐,调节尿离子浓度。结论利拉鲁肽通过调节2型糖尿病大鼠血压和尿离子浓度,发挥其肾脏保护作用。 Objective To observe the protective effect of Liraglutide on kidney in type 2 diabetic rats. Methods The male SD rats were injected with streptozotocin (STZ) in fasting condition by intraperitoneal injection after 6-week high-fat and high-sugar feeding to establish the type 2 diabetic rat models. The type 2 diabetic rats were given Liraglutide 200btg/kg each day by subcutaneous injection for 6 weeks, and the changes of blood glucose, blood pressure, body weight, urea nitrogen, serum creatinine and ion concentration in urine were detected. Results Liraglutide decreased the blood glucose, blood pressure, body weight, urea nitrogen and serum creatinine and regulated the ion concentration in urine in the type 2 diabetic rat models in an effective way. Conclusion Liraglutide can exert a protective effect on the kidney by regulating the blood pressure and urinary ionic concentration in type 2 diabetic rats.
作者 王少清 汪力 高芳 毛楠 王小文 Wang Shaoqing Wang LiA Gao Fang Mao Nan Wang Xiaowen.(Department of Nephrology, The First Affiliated Hospital of Chengdu Medical College, Chengdu 610500, China)
出处 《成都医学院学报》 CAS 2016年第6期681-683,共3页 Journal of Chengdu Medical College
基金 四川省教育厅科研资助重点项目(No:13ZA0213) 四川省卫生厅科研资助项目(No:130386) 成都医学院"驼鸟计划"2012年专项基金资助项目(No:CYX12-024) 2014年成都医学院大学生创新实验计划项目(No:CXXS201422)
关键词 利拉鲁肽 2型糖尿病 链脲佐菌素 Liraglutide Type 2 diabetes Streptozotocin
  • 相关文献

参考文献1

二级参考文献10

  • 1Verdecchia P, Angeli F, Gattobigio R, et al. Impact of blood pres- sure variability on cardiac and cerebrovascular complications in hy- pertension[J]. Am J Hypertens, 2007, 20(2): 154-161.
  • 2Ussher JR, Drucker DJ. Cardiovascular biology of the incretin sys- tem[J].Endocr Rev, 2012,33(2):187-215.
  • 3Zakopoulosa NA, Tsivgoulisb G, Barlas G, et al.Impact of the time rate of blood pressure variation on left ventricular mass[J]. J Hyper tens ,2006,24( 10):2071-2077.
  • 4Poulos NA, Tsivgoulis G, Barlas G, et al. Time rate of blood pres- sure variation is associated with increased common carotid artery in- tima-media thickness[J]. Hypertension, 2005, 45(4):505-512.
  • 5Kesavadev J, Shankar A, Krishnan G, et al.Liraglutide therapy be- yond glycemic control: an observational study in Indian patients with type 2 diabetes in real world setting[J].Int J Gen Med,2012,5: 317-322.
  • 6Sander D, Kukla C, Klingelhofer J, et al. Relationship between cir- cadian blood pressure patterns and progression of early carotid ath- erosclerosis A 3-year follow up study[J].Circulation, 2000, 102 (13): 1536-1541.
  • 7Tatasciore A, Renda G, Zinarino M, et al. Awake Systolic blood pressure variability correlates with target organ damage in hyperten- sive subjects[J]. Hypertension, 2007, 50(2): 325-332.
  • 8Mancia G, Bombelli M, Facchetti R, et al. Long-term prognostic val- ue of blood pressure variability in the general population[J].Hyper- tension,2007,49(6): 1265-1270.
  • 9Frattola A, Parati G, Castiglioni P, et al. Lacidipine and blood pres- sure variability in diabetic hypertensive patients[J]. Hypertension, 2000,36(4):622-628.
  • 10Masuda S,Tamura K. Effects of angiotensin II type 1 receptor block- er on ambulatory blood pressure variability in hypertensive patients with overt diabetic nephropathy[J]. Hypertens Res, 2009,32(11): 950-955.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部